Evidence map›Paper›PMID 27378573›Full record

ReviewInternal and emergency medicine2016

Effect of colchicine in prevention of pericardial effusion and atrial fibrillation: a meta-analysis.

Ming-Xuan Wang, Xiao-Long Deng, Bing-Yao Mu, Yong-Jing Cheng, Ying-Juan Chen, Qian Wang, Jia Huang, Rong-Wei Zhou, Ci-Bo Huang

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Internal and emergency medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07611019 (Randomized, Double-Blind, Placebo-Controlled Trial of Colchicine to Prevent Post-Operative Atrial Fibrillation After CABG With Strategy-Stratified Randomization), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07611019 phase2 / phase3enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Randomized, Double-Blind, Placebo-Controlled Trial of Colchicine to Prevent Post-Operative Atrial Fibrillation After CABG With Strategy-Stratified Randomization

TypeinterventionalSponsorNational Taiwan University HospitalRan2026 to 2028Enrolled400ConditionsPost-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)ArmsColchicine 0.5 MG oral tablet twice daily, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Colchicine for the primary prevention of cardiovascular events.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ming-Xuan WangDepartment of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xiao-Long DengDepartment of Neurology, Wuhan Medical & Healthcare Center for Women and Children, Wuhan Children's Hospital, Wuhan, Hubei, China.
Bing-Yao MuDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Yong-Jing ChengDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Ying-Juan ChenDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Qian WangDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Jia HuangDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Rong-Wei ZhouDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China.
Ci-Bo HuangDepartment of Rheumatology, Beijing Hospital, No. 1, Dahua Road, East District, Beijing, China. huangcb1208@sina.com.
Beijing Hospital · CNCapital Medical University · CNWuhan Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Randomized, controlled trials (RCTs) have assessed the effect of colchicine therapy in prevention of pericardial effusion (PE) and atrial fibrillation (AF). However, the effects are still inconclusive. PubMed, Cochrane Library, Google Scholar, and EMBASE database were searched. Primary outcome was the risk of PE and AF. Ten RCTs with 1981 patients and a mean follow-up of 12.6 months were included. Colchicine therapy was not associated with a significantly lower risk of post-operative PE (RR, 0.89; 95 % CI 0.70-1.13; p = 0.33, I (2) = 72.8 %) and AF (RR, 0.77; 95 % CI 0.52-1.13; p = 0.18, I (2) = 47.3 %). However, rates of pericarditis recurrence, symptoms persistence, and pericarditis-related hospitalization were significantly decreased with colchicine treatment. In addition, cardiac tamponade occurrence was similar between groups, and adverse events were significantly higher in the colchicine group. Colchicine may not significantly decrease the post-operative risk of PE and AF. However, only limited studies about patients undergoing cardiac surgery provide data about PE and AF.

Indexed as

Atrial FibrillationCardiac Surgical ProceduresChi-Square DistributionColchicineHumansPericardial EffusionPericarditisRecurrenceColchicineAtrial fibrillationCardiac tamponadeColchicinePericardial effusionPericarditis recurrence

Identifiers

PMID27378573
OpenAlexW2468717398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.